Page 3 - Target Validation News Today

Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH. The aim is to neutralise only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the

Share this article Share this article Catheter Market has witnessed strong growth owing to the huge prevalence of cardiovascular diseases, coupled with the advancement of unique-feature enhanced cardiovascular catheters. Chronic disorders such as cardiovascular, neurology, and urology disorders have become the most imperative cause of mortality and morbidity across the globe, during the last three decades. JERSEY CITY, N.J., Feb. 8, 2021 /PRNewswire/ -- Verified Market Research recently publish...